Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
07/04/1995 | US5429823 Phosphatidylcholine and sphingomyelin |
07/04/1995 | CA1336166C Further improvements relating to drug delivery systems |
07/01/1995 | CA2138876A1 Composition against aging by acting simultaneously on the superficial and deep layers of the skin, and its use |
06/29/1995 | WO1995017433A1 Use of mono-3,6-anhydro-cyclodextrins for solubilising a hydrophobic compound and monitoring the purity of an enantiomer, and method for preparing said cyclodextrins |
06/29/1995 | WO1995017432A1 Cyclodextrin derivatives for solubilising hydrophobic chemical compounds such as drugs, and methods for preparing same |
06/29/1995 | WO1995017428A1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions |
06/29/1995 | WO1995017378A1 Compound capable of introducing at least one molecule into a cell |
06/29/1995 | WO1995017212A1 Conjugates consisting of peptidic t cell antigens and cell binding partners and their use for therapy |
06/29/1995 | WO1995017210A1 Vaccines |
06/29/1995 | WO1995017209A1 Vaccines |
06/29/1995 | WO1995017207A1 Parathyroid hormone formulation |
06/29/1995 | WO1995017191A1 Use of amino cyclodextrins for the aqueous solubilisation of dibenzazepines for use as an antiepileptic agent. |
06/29/1995 | WO1995017187A1 Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin |
06/29/1995 | WO1995017179A1 Stable dermatologic preparation containing mycophenolic acid |
06/29/1995 | WO1995017170A1 Accelerated release composition containing bromocriptine |
06/29/1995 | WO1995017169A1 Method for dry blend compression of medicaments |
06/29/1995 | WO1995017166A1 Wound hydrating gel with novel preservative system and low cytotoxicity |
06/29/1995 | WO1995017165A2 Tissue moisturizing and antimicrobial compositions |
06/29/1995 | DE4344697A1 New lotion is water-oil emulsion compsn. contg. corticosteroid |
06/29/1995 | DE4344661A1 New citronellyl, geranyl, farnesyl, phytyl or iso-phytyl ester cpds |
06/29/1995 | CA2179385A1 Compound capable of introducing at least one molecule into a cell |
06/29/1995 | CA2156396A1 Stable dermatologic preparation containing mycophenolic acid |
06/29/1995 | CA2138853A1 Highly concentrated immunoglobulin preparation and method for its production |
06/28/1995 | EP0659767A1 Process to prepare an anti-D immunoglobulin G concentrate and pharmaceutical compositions comprising it |
06/28/1995 | EP0659440A1 Calcium-modified oxidized cellulose hemostat |
06/28/1995 | EP0659439A2 Immunoconjugates |
06/28/1995 | EP0659438A1 Conjugates consisting of peptidic T cell antigens and cell binding groups, and their use for therapy |
06/28/1995 | EP0659435A1 Injectable ready-to-use solutions containing an antitumour anthracycline glycoside |
06/28/1995 | EP0659403A2 Use of oil adsorbent natural polymer for cosmetic and pharmaceutical applications |
06/28/1995 | EP0659402A2 Formulations containing carotenoids and procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals |
06/28/1995 | EP0659084A1 Medical preparations containing n-methylated cyclic undecapeptides. |
06/28/1995 | EP0659081A1 Dexpanthenol-containing plaster for the transdermal application of steroid hormones |
06/28/1995 | EP0659080A1 Method and composition for the treatment of hair loss |
06/28/1995 | EP0659073A1 Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
06/28/1995 | EP0659072A1 Pharmaceutical emulsions containing bioactive steroids |
06/28/1995 | EP0465556B1 Platelet specific immunoconjugates |
06/28/1995 | EP0401302B1 Method of preparing a metal-radionuclide-labelled protein |
06/28/1995 | CN1104256A New method of making crystalline sugar and products resulting therefrom |
06/28/1995 | CN1104041A Method for suppressing bitter taste |
06/27/1995 | US5428133 Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils |
06/27/1995 | US5428132 Conjugate and method for integration of foreign DNA into cells |
06/27/1995 | US5428023 Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof |
06/27/1995 | US5428006 Including an n-glycofurol; improves absorption through mucous membranes |
06/27/1995 | US5427814 Mixing a fat with a synergic antioxidant desolventized mixture consisting of tocopherol, lecithin and ascorbic acid |
06/27/1995 | US5427798 Controlled sustained release tablets containing bupropion |
06/27/1995 | US5427778 Gel formulations containing growth factors and acrylamide polymer |
06/27/1995 | US5427767 Particles having crosslinked coatings of natural or synthetic mucopolysaccharides, for contrast in nuclear magnetic resonance imaging |
06/27/1995 | CA1336087C Polysaccharide esters |
06/27/1995 | CA1336069C Chewable medicament tablet containing means for taste masking |
06/22/1995 | WO1995016659A1 Novel retinoid conjugate compounds and methods for treating skin aging |
06/22/1995 | WO1995016465A1 Pharmaceutical compositions containing alkyl polyoxyalkylene carboxylates |
06/22/1995 | WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy |
06/22/1995 | WO1995016460A1 Composition containing soluble thrombomodulins |
06/22/1995 | WO1995016445A1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid |
06/22/1995 | WO1995016444A1 Composition and method for producing local anesthesia of the skin |
06/22/1995 | WO1995016441A1 Ultramicroemulsions from spontaneously dispersible concentrates with pharmacologically effective esters of apocarotinols |
06/22/1995 | WO1995016437A1 Method of transmitting a biologically active material to a cell |
06/22/1995 | WO1995016436A1 Lipid vesicles containing avocado oil unsaponifiables |
06/22/1995 | WO1995016434A1 Sucrose ester c-20 to c-28 alcohol formulations |
06/22/1995 | WO1995016430A2 Cosmetic and/or pharmaceutical preparations |
06/22/1995 | WO1995016359A1 Growth promoting composition for fish |
06/22/1995 | WO1995009611A3 Stable protein: phospholipid compositions and methods |
06/22/1995 | DE4407742C1 Transdermal patch for treating tumours |
06/22/1995 | CA2178964A1 Novel retinoid conjugate compounds and methods for treating skin aging |
06/22/1995 | CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy |
06/21/1995 | EP0658629A1 Process for preparation of polyol fatty acid ester and glyceride mixture obtained |
06/21/1995 | EP0658624A2 Recombinant genes expressing pp14 |
06/21/1995 | EP0658596A2 Composition based on biopolymers with rapid hydration |
06/21/1995 | EP0658585A2 Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants |
06/21/1995 | EP0658568A1 Glucagon-like insulinotropic peptides, compositions and methods |
06/21/1995 | EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins |
06/21/1995 | EP0658347A2 Pharmaceutical composition, containing diclofenac and 2-hydroxypropyl-beta-cyclodextrin |
06/21/1995 | EP0658210A1 Translocation signal facilitated nuclear delivery of macromolecules |
06/21/1995 | EP0658121A1 Film-forming x-ray contrast compositions |
06/21/1995 | EP0658118A1 Vaccines against group c neisseria meningitidis |
06/21/1995 | EP0658112A1 A novel conjugate, its preparation and use and a substrate prepared with the conjugate |
06/21/1995 | EP0658111A1 Methods for enhancing drug delivery with modified saponins |
06/21/1995 | EP0658105A1 Local drug delivery film for periodontal treatment |
06/21/1995 | EP0557399B1 Foamable washing composition based on selected insoluble silicones and an alkylpolyglycoside, and cosmetic and dermatological uses thereof |
06/21/1995 | EP0550704B1 Biotenside esters with vitamin d compounds; their preparation and transformation into spontaneously dispersible concentrates, and their use for treating tumors |
06/21/1995 | EP0543988B1 Process for producing magnetically responsive polymer particles and application thereof |
06/21/1995 | EP0540588B1 A composition providing improved clearance of bioactive substances from the bloodstream |
06/21/1995 | CN1103871A Bile acid sequestrant |
06/21/1995 | CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition |
06/21/1995 | CN1028961C Pharmaceutical solution |
06/20/1995 | US5426182 Used as stabilizers and thickeners in latex compositions; ether-containing hydroxy compounds having hydrophobic groups such as alkyl, aryl, alkylaryl etc |
06/20/1995 | US5426048 DNA encoding a fusion receptor for oncostatin M and leukemia inhibitory factor |
06/20/1995 | US5425950 Antiserotonine agent |
06/20/1995 | US5425943 Modified tPA-containing injection composition having increased solubility |
06/20/1995 | CA1336034C Biodegradable polypeptide and the use thereof for the gradual release of drugs |
06/16/1995 | CA2137119A1 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015770A1 Pretargeting methods and compounds |
06/15/1995 | WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
06/15/1995 | WO1995015754A1 Transdermal delivery device |
06/15/1995 | WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
06/15/1995 | WO1995015748A1 Microsphere drug delivery system |
06/15/1995 | WO1995015747A1 Local delivery of fibrinolysis enhancing agents |
06/15/1995 | WO1995015746A1 Liposome delivery systems |